Context Therapeutics (CNTX) Income Statement: Revenue & Earnings

Context Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Context Therapeutics Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	22.70	17.78	7.09	3.81	1.64
Selling, General & Administrative	7.22	7.29	7.79	3.63	0.93
Operating Expenses	29.92	25.07	14.88	7.44	2.57
Operating Income	-29.92	-25.07	-15.38	-7.44	-2.57
Other Income/Expense
Interest Income	3.20	1.16	0.55	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.06	-0.66
Other Income/Expense	3.20	-0.06	-0.50	-2.95	9.88
Income
Income Before Tax	-26.73	-23.96	-14.84	-10.46	6.64
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-26.73	-23.96	-14.84	-10.46	6.64
Net Income - Continuous Operations	-26.73	-23.96	-14.84	-10.46	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-29.91	-25.06	-14.87	-10.39	0.00
EBIT	-26.73	-25.07	-14.88	-10.39	-2.57
Depreciation & Amortization	0.01	0.01	0.01	0.00	0.00
Earnings Per Share
Basic EPS	-	-1.00	-1.00	-4.00	3.00
Diluted EPS	-	-1.00	-1.00	-4.00	-4.00
Basic Shares Outstanding	58.42	15.97	15.97	2.83	0.35
Diluted Shares Outstanding	58.42	15.97	15.97	2.83	2.05